GlassScriptPhysician profile
Ayman D Yaish
NPI 1346450558
$5,468.87
in general payments reported to CMS, 2019-2025
28 companies · $994 in 2025
The $994 reported for 2025 was more than what 82% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $700 · 2021: $633 · 2022: $920 · 2023: $762 · 2024: $490 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,066 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,066.05 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $1,674.00 | 2019-2021 | |
| Inspire Medical Systems, INC. | $1,069.54 | 2022-2025 | Inspire |
| Optinose US, INC. | $727.44 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $532.01 | 2019-2025 | |
| Medtronic, INC. | $184.16 | 2022-2024 | Propel |
| Genzyme Corporation | $159.31 | 2022-2025 | |
| Stryker Corporation | $149.70 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $136.45 | 2019-2021 | |
| Aerin Medical INC. | $121.28 | 2021-2025 | |
| Xoran Technologies LLC | $120.00 | 2022 | |
| Karl Storz Endoscopy-America | $118.55 | 2019-2021 | |
| Harmony Biosciences LLC | $116.11 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $48.13 | 2022-2023 | Dupixent |
| Neurent Medical Limited | $28.92 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Acera Surgical, INC. | $28.63 | 2025 | Restrata Wound Matrix |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $28.17 | 2019 | |
| Organogenesis INC. | $26.91 | 2023 | Puraply |
| Alk-Abello, INC | $24.73 | 2025 | Pre-Pen, Histamine Positive |
| Philips North America LLC | $24.38 | 2019-2020 | |
| Glaxosmithkline, LLC. | $19.72 | 2025 | Nucala |
| Genentech USA, INC. | $19.70 | 2021 | |
| Resmed Corp | $18.82 | 2025 | |
| Baxter Healthcare | $18.33 | 2024 | Perclot |
| Lilly USA, LLC | $16.75 | 2025 | Zepbound |
| Olympus America INC. | $16.43 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.50 | 2025 | |
| Itamar Medical INC | $14.36 | 2023 | Watchpatone |
| Integra Lifesciences Corporation | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayman Yaish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.